REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 66 filers reported holding REGULUS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,691,618 | – | 947,685 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,111,049 | $1,633,242 | 0.45% |
| Sarissa Capital Management LP | 185,183 | $272,219 | 0.03% |
| FEDERATED HERMES, INC. | 3,875,578 | $5,697,100 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 40,660 | $59,770 | 0.00% |
| GRIMES & COMPANY, INC. | 10,363 | $15,234 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,612 | $5,310 | 0.00% |
| Community Bank, N.A. | 690 | $1,014 | 0.00% |
| OSAIC HOLDINGS, INC. | 50 | $73 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 112,622 | $165,554 | 0.00% |